- Predicting Prostate Cancer Death with Different Pretreatment Risk ...🔍
- Understanding Prostate Cancer Risk Factors🔍
- Objective risk stratification of prostate cancer using machine ...🔍
- Role of ADT and Genomic Risk Stratification for Patients ...🔍
- Prostate Cancer🔍
- Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate ...🔍
- Prostate Cancer with Additional Treatment and Risk Stratification ...🔍
- Impact of the 17|Gene Genomic Prostate Score Assay🔍
Prostate cancer stratification with diverse biologically|informed ...
Predicting Prostate Cancer Death with Different Pretreatment Risk ...
The MSKCC nomogram, CAPRA score, and CPG risk grouping system performed better in discriminating prostate cancer death than the D'Amico and D' ...
Understanding Prostate Cancer Risk Factors: Age, Family History ...
With approximately 1 in 8 men diagnosed in their lifetime, prostate cancer is one of the most common cancers among men. Understanding the various risk factors ...
Objective risk stratification of prostate cancer using machine ...
This paper presents a systematic and rigorous framework comprised of classification, cross-validation and statistical analyses that was developed to identify ...
Role of ADT and Genomic Risk Stratification for Patients ... - UroToday
The Oncotype DX prostate biopsy test calculates a genomic prostate score (GPS) based on genes from four different pathways involved in prostate cancer. The ...
Prostate Cancer - Guidelines Detail - NCCN
Prostate Cancer · Guidelines · Evidence Blocks · Frameworks · Guidelines for Patients · Educational Events and Programs · International · Disclosures.
Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate ...
Polygenic risk scores (PRSs) of common genetic variants have shown promise in prostate cancer risk stratification, but their validity across populations has yet ...
Definitions of biochemical recurrence and prostate-specific antigen (PSA) persistence: · Definitions of hormone-sensitive (castration-sensitive) ...
Prostate Cancer with Additional Treatment and Risk Stratification ...
The Prostate Cancer database now includes several variables not released as part of the SEER Research Plus Data, which inform about the prognostic risk at the ...
Impact of the 17-Gene Genomic Prostate Score Assay
Background: Active surveillance (AS) has been widely implemented within Veterans Affairs' medical centers (VAMCs) as a standard of care for ...
Diagnosis and staging of patients with prostate cancer - Lenus.ie
Network® (NCCN®) prostate cancer risk stratification(Referenced with permission from the NCCN ... Prostate. Cancer: An Analysis Informed by the ...
Using the Cambridge Prognostic Groups for risk stratification of ...
Several risk stratification tools exist which are used in different countries and contexts to classify prostate cancer. Studies have shown that ...
Genetic Testing for Prostate Cancer
This testing is performed on tumor tissue from biopsy samples or after prostatectomy and looks for several different characteristics of the cancer – including ...
Imaging and Pathology Correlations for Different Risk Stratification ...
Prostate cancer is a highly heterogeneous disease which was initially stratified into low, intermediate, and high-risk groups to help guide therapy and ...
Prostate Cancer: Practice Essentials, Background, Anatomy
Marked variation in rates of prostate cancer among populations in different parts of the world suggests the involvement of genetic factors.
A European Model for an Organised Risk-stratified Early Detection ...
Overdiagnosis as the argument to stop prostate cancer (PCa) screening is less valid since the introduction of new technologies such as risk ...
Prostate Cancer - Uroweb - European Association of Urology
Future goals. Results of ongoing and new SRs will be included in the 2025 update of the PCa Guidelines: A SR assessing the performance of risk stratification ...
Risk Stratification - 2021 Prostate Cancer Patient Conference
The California Prostate Cancer Coalition (CPCC) and The Helen Family Diller Comprehensive Cancer Center present the 2021 Patient Conference ...
A discovery and validation cohor - The Lancet
Methods: In a study of 482 tumour, benign and germline samples from 259 men with primary prostate cancer, we used integrative analysis of copy ...
Different outcomes among favourable and unfavourable ...
to evaluate the role of a risk stratification system in intermediate-risk prostate cancer (PCa) treated with hypofractionated radiotherapy ...
Initial prospective study of developmental endothelial locus-1 protein
Identification of a novel non-invasive biological marker to overcome the shortcomings of PSA in diagnosis and risk stratification for prostate ...